Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sildenafil + tadalafil
- Development stage
- Phase 4
- Lead developer
- Aspargo Laboratories
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A combination of sildenafil and tadalafil, two potent phosphodiesterase type 5 (PDE5) inhibitors, primarily indicated for the treatment of erectile dysfunction. Sildenafil provides a rapid onset of action, typically within 30 to 60 minutes, while tadalafil offers a significantly longer duration of effect, lasting up to 36 hours. This combination is frequently utilized in compounded formulations or specialized delivery formats such as chewable tablets and mints by telehealth providers. In clinical research conducted by Aspargo Labs, these combination products serve as reference comparators for evaluating the pharmacokinetic profile and bioavailability of proprietary liquid sildenafil suspensions like Hezkue (ASP-001) and Hezkue Turbo (ASP-001.1).
- Brand names
- Ro SparksHims Hard MintsBlueChewHello Cake ED Cake Meds
- Other names
- sildenafil and tadalafil combinationtadalafil + sildenafil
02
Targets
PDE1 (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase)PDE11A (Phosphodiesterase 11A)PDE3PDE5 (Phosphodiesterase 5A)PDE6 (Phosphodiesterase 6)PDE8A (Phosphodiesterase 8A)
Beyond the preview
Go deeper on sildenafil + tadalafil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sildenafil + tadalafil.